Engineered ChymotrypsiN for Mass Spectrometry-Based Detection of Protein Glycosylation

被引:14
|
作者
Ramesh, Balakrishnan [1 ]
Abnouf, Shaza [1 ]
Mali, Sujina [2 ]
Moree, Wilna J. [2 ]
Patil, Ujwal [2 ]
Bark, Steven J. [2 ]
Varadarajan, Navin [1 ]
机构
[1] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA
[2] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
YEAST EXTERNAL INVERTASE; CONVERTING TRYPSIN; SUBSTRATE-SPECIFICITY; ENRICHMENT METHODS; CRYSTAL-STRUCTURE; SITES; PROTEOMICS; PROTEASES; EVOLUTION; ACTIVATION;
D O I
10.1021/acschembio.9b00506
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have engineered the substrate specificity of chymotrypsin to cleave after Asn by high-throughput screening of large libraries created by comprehensive remodeling of the substrate binding pocket. The engineered variant (chymotrypsiN, ChyB-Asn) demonstrated an altered substrate specificity with an expanded preference for Asn-containing substrates. We confirmed that protein engineering did not compromise the stability of the enzyme by biophysical characterization. Comparison of wild-type ChyB and ChyB-Asn in profiling lysates of HEK293 cells demonstrated both qualitative and quantitative differences in the nature of the peptides and proteins identified by liquid chromatography and tandem mass spectrometry. ChyB-Asn enabled the identification of partially glycosylated Asn sites within a model glycoprotein and in the extracellular proteome of Jurkat T cells. ChymotrypsiN is a valuable addition to the toolkit of proteases to aid the mapping of N-linked glycosylation sites within proteins and proteomes.
引用
收藏
页码:2616 / 2628
页数:13
相关论文
共 50 条
  • [31] Development of a Mass Spectrometry-Based Assay for the Detection of Endogenous and Lentiviral Engineered Enhanced Hemoglobin in Sickle Cells and Mice
    Wang, Xuejun
    Dlugi, Theresa A.
    Faber, Mary L.
    McKillop, William M.
    Argote, Juliana Alvarez
    Wilber, Andrew C.
    Medin, Jeffrey A.
    MOLECULAR THERAPY, 2023, 31 (04) : 518 - 519
  • [32] Recent Advances in Mass Spectrometry-Based Protein Interactome Studies
    Wu, Shaowen
    Zhang, Sheng
    Liu, Chun-Ming
    Fernie, Alisdair R.
    Yan, Shijuan
    MOLECULAR & CELLULAR PROTEOMICS, 2025, 24 (01)
  • [33] Mass spectrometry-based strategies for protein disulfide bond identification
    Tsai, Pei Lun
    Chen, Sung-Fang
    Huang, Sheng Yu
    REVIEWS IN ANALYTICAL CHEMISTRY, 2013, 32 (04) : 257 - 268
  • [34] Mass spectrometry-based protein identification in proteomics-a review
    Noor, Zainab
    Ahn, Seong Beom
    Baker, Mark S.
    Ranganathan, Shoba
    Mohamedali, Abidali
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (02) : 1620 - 1638
  • [35] Mass spectrometry-based characterization of acidic glycans on protein therapeutics
    Salinas, Paul A.
    Miller, May Joy C.
    Lin, Melanie X.
    Savickas, Phil J.
    Thomas, John J.
    INTERNATIONAL JOURNAL OF MASS SPECTROMETRY, 2012, 312 : 122 - 134
  • [36] Mass spectrometry-based protein biomarker discovery in neurodevelopmental disorders
    Wormwood, Kelly
    Wetie, Armand Ngounou
    Charette, Laci
    Ryan, Jeanne
    Dupree, Emmalyn
    Woods, Alisa
    Darie, Costel
    PROTEIN SCIENCE, 2015, 24 : 244 - 245
  • [37] Mass spectrometry-based approaches to protein-ligand interactions
    Schermann, SM
    Simmons, DA
    Konermann, L
    EXPERT REVIEW OF PROTEOMICS, 2005, 2 (04) : 475 - 485
  • [38] Advances in mass spectrometry-based epitope mapping of protein therapeutics
    Liu, Xiaoran Roger
    Huang, Richard Y-C
    Zhao, Feifei
    Chen, Guodong
    Tao, Li
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2022, 215
  • [39] Mass spectrometry-based targeted proteomics for analysis of protein mutations
    Lin, Tai-Tu
    Zhang, Tong
    Kitata, Reta B.
    Liu, Tao
    Smith, Richard D.
    Qian, Wei-Jun
    Shi, Tujin
    MASS SPECTROMETRY REVIEWS, 2023, 42 (02) : 796 - 821
  • [40] Mass spectrometry-based diagnostics: The upcoming revolution in disease detection
    Petricoin, EF
    Liotta, LA
    CLINICAL CHEMISTRY, 2003, 49 (04) : 533 - 534